https://arolstar52-zhtest.hf.space/index.php?action=history&feed=atom&title=Template%3APeptidergics
Template:Peptidergics - 版本历史
2026-07-19T04:41:56Z
本wiki上该页面的版本历史
MediaWiki 1.43.9
https://arolstar52-zhtest.hf.space/index.php?title=Template:Peptidergics&diff=2576575&oldid=prev
imported>Cewbot：清理導航模板中裸露的可折疊選項模板，改用{{Navbox documentation}}。
2025-12-30T23:09:22Z
<p><a href="/index.php?title=User:Cewbot/log/20251126/configuration&action=edit&redlink=1" class="new" title="User:Cewbot/log/20251126/configuration（页面不存在）">清理導航模板中裸露的可折疊選項模板</a>，改用{{Navbox documentation}}。</p>
<p><b>新页面</b></p><div>{{Navbox<br />
| name = Peptidergics<br />
| title = [[肽]]類<br />
| state = {{{state<includeonly>|collapsed</includeonly>}}}<br />
| listclass = hlist<br />
<br />
<br />
| group1 = [[血管紧张素受体]]<br />
| list1 = <br />
* '''激動劑:''' [[血管紧张素|血管紧张素II]]<br />
* [[血管紧张素|血管紧张素III]]<br />
* [[Angiotensin IV]]<br />
* [[Saralasin]]<br />'''拮抗劑:''' [[Abitesartan]]<br />
* [[阿齐沙坦]]<br />
* [[阿齐沙坦|阿齊沙坦酯]]<br />
* [[坎地沙坦]]<br />
* [[Elisartan]]<br />
* [[Embusartan]]<br />
* [[Eprosartan]]<br />
* [[EXP-3174]]<br />
* [[Fimasartan]]<br />
* [[Forasartan]]<br />
* [[厄贝沙坦]]<br />
* [[Losartan]]<br />
* [[Milfasartan]]<br />
* [[奥美沙坦]]<br />
* [[奥美沙坦|奧美沙坦酯]]<br />
* [[PD123319]]<br />
* [[Pomisartan]]<br />
* [[Pratosartan]]<br />
* [[Ripisartan]]<br />
* [[Saprisartan]]<br />
* [[Tasosartan]]<br />
* [[替米沙坦]]<br />
* [[缬沙坦]]<br />
* [[Zolasartan]]<br />
<br />
| group2 = [[緩激肽受體]]<br />
| list2 = <br />
* '''激動劑:''' [[缓激肽]]<br />
* [[Kallidin]]<br />'''拮抗劑:''' [[FR-173657]]<br />
* [[Icatibant]]<br />
* [[LF22-0542]]<br />
<br />
| group3 = [[生长激素受体|GH]]<br />
| list3 = <br />
* '''激動劑:''' [[牛生长激素]]<br />
* [[Human placental lactogen]]<br />
* [[生长激素]]<br />
* [[Somatrem]]<br />'''拮抗劑:''' [[Pegvisomant]]<br />
<br />
| group4 = [[生長激素釋放激素受體|GHRH]]<br />
| list4 = <br />
* '''激動劑:''' <br />
* [[Dumorelin]]<br />
* [[Growth-hormone-releasing hormone|GHRH (somatorelin)]]<br />
* [[GHRH (1-29)]]<br />
* [[Rismorelin]]<br />
* [[Sermorelin]]<br />
* [[Tesamorelin]]<br />'''拮抗劑:''' [[MZ-5-156]]<br />
<br />
| group5 = [[生長激素促分泌素受體|生長素/GHS]]<br />
| list5 = <br />
* '''激動劑:''' [[腺苷]]<br />
* [[Anamorelin]]<br />
* [[Capromorelin]]<br />
* [[Cortistatin-14]]<br />
* [[Examorelin|Examorelin (hexarelin)]]<br />
* [[Ghrelin|Ghrelin (lenomorelin)]]<br />
* [[GHRP-6]]<br />
* [[Ibutamoren]]<br />
* [[Ipamorelin]]<br />
* [[L-692,585]]<br />
* [[Macimorelin]]<br />
* [[Pralmorelin|Pralmorelin (GHRP-2)]]<br />
* [[Relamorelin]]<br />
* [[SM-130,686]]<br />
* [[Tabimorelin]]<br />
* [[Ulimorelin]]<br />'''拮抗劑:''' [[A-778,193]]<br />
* [[Cortistatin-8]]<br />
* [[(D-Lys3)-GHRP-6|(<small>D</small>-Lys<sup>3</sub>)-GHRP-6]]<br />
* [[YIL-781]]<br />
<br />
| group6 = [[胰高血糖素樣肽受體|GLP]]<br />
| list6 = {{Navbox subgroup<br />
<br />
<br />
| group1 = [[Glucagon-like peptide 1 receptor|GLP-1]]<br />
| list1 =<br />
* '''激動劑:''' [[Albiglutide]]<br />
* [[Dulaglutide]]<br />
* [[艾塞那肽]]<br />
* [[胰高血糖素样肽-1|GLP-1]]<br />
* [[Langlenatide]]<br />
* [[利拉鲁肽]]<br />
* [[Lixisenatide]]<br />
* [[Oxyntomodulin]]<br />
* [[司美格鲁肽]]<br />
* [[Taspoglutide]]<!--<br />'''拮抗劑:'''--><br />
<br />
| group2 = [[Glucagon-like peptide 2 receptor|GLP-2]]<br />
| list2 =<br />
* '''激動劑:''' [[Elsiglutide]]<br />
* [[Glucagon-like peptide 2|GLP-2]]<br />
* [[Teduglutide]]<!--<br />'''拮抗劑:'''--><br />
<br />
}}<br />
<br />
| group7 = [[胰高血糖素受體]]<br />
| list7 = <br />
* '''激動劑:''' [[胰高血糖素]]<br />'''拮抗劑:''' [[L-168,049]]<br />
* [[LGD-6972]]<br />
<br />
| group8 = [[促性腺激素釋放激素受體|GnRH]]<br />
| list8 = <br />
* '''激動劑:''' [[Avorelin]]<br />
* [[Buserelin]]<br />
* [[Deslorelin]]<br />
* [[促性腺激素释放激素]]<br />
* [[Goserelin]]<br />
* [[Histrelin]]<br />
* [[Leuprorelin]]<br />
* [[Lutrelin]]<br />
* [[Nafarelin]]<br />
* [[Peforelin]]<br />
* [[Triptorelin]]<br />
* [[Zoptarelin doxorubicin]]<br />'''拮抗劑:''' [[Abarelix]]<br />
* [[Cetrorelix]]<br />
* [[Degarelix]]<br />
* [[Detirelix]]<br />
* [[Elagolix]]<br />
* [[Ganirelix]]<br />
* [[Iturelix]]<br />
* [[Ozarelix]]<br />
* [[Prazarelix]]<br />
* [[Ramorelix]]<br />
* [[Teverelix]]<br />
<br />
| group9 = [[促性腺激素受體]]<br />
| list9 = {{Navbox subgroup<br />
<br />
<br />
| group1 = [[黄体生成素/绒毛膜促性腺激素受体|LH/CG]]<br />
| list1 =<br />
* '''激動劑:''' [[人绒毛膜促性腺激素]]<br />
* [[黄体生成素]]<!--<br />'''拮抗劑:'''--><br />
<br />
| group2 = [[促卵泡激素受体|FSH]]<br />
| list2 =<br />
* '''激動劑:''' [[促卵泡激素]]<!--<br />'''拮抗劑:'''--><br />
<br />
}}<br />
<br />
| group10 = [[胰島素受體]]<br />
| list10 = <br />
* '''激動劑:''' [[胰岛素样生长因子1|IGF-1]]<br />
* [[Insulin-like growth factor 2|IGF-2]]<br />
* [[胰岛素]]<br />
* [[门冬胰岛素]]<br />
* [[Insulin degludec]]<br />
* [[地特胰岛素注射液]]<br />
* [[Insulin glargine]]<br />
* [[Insulin glulisine]]<br />
* [[Insulin lispro]]<br />'''拮抗劑:''' [[S661]]<br />
* [[S961]]<br />
<br />
| group11 = [[KISS1衍生肽受體]]<br />
| list11 = <br />
* '''激動劑:''' [[Kisspeptin]]<br />
* [[Kisspeptin-10]]<br />'''拮抗劑:''' [[Kisspeptin-234]]<br />
<br />
| group12 = [[瘦素受體]]<br />
| list12 = <br />
* '''激動劑:''' [[瘦素|瘦蛋白]]<br /><!--'''拮抗劑:'''--><br />
<br />
| group13 = [[神經肽受體]]<br />
| list13 = 參見[[Template:Neuropeptidergics|here]]<br />
<br />
| group14 = [[神经营养因子|神經營養因子受體]]<br />
| list14 = 參見[[Template:Neurotrophinergics|here]]<br />
<br />
| group15 = [[催乳素受体]]<br />
| list15 = <br />
* '''激動劑:''' [[Human placental lactogen]]<br />
* [[催乳素]]<br />
* [[生长激素]]<!--<br />'''拮抗劑:'''--><br />
<br />
| group16 = [[甲狀旁腺激素受體|PTH]]<br />
| list16 = <br />
* '''激動劑:''' [[Abaloparatide]]<br />
* [[副甲狀腺素|PTH]]<br />
* [[Parathyroid hormone-related protein|PTHrP]]<br />
* [[Semparatide]]<br />
* [[特立帕肽]]<!--<br />'''拮抗劑:'''--><br />
<br />
| group17 = [[促生長因子受體]]<br />
| list17 = {{Navbox subgroup<br />
<br />
<br />
| group1 = [[I胰岛素样生长因子1受体|IGF-1]]<br />
| list1 =<br />
* '''激動劑''': [[胰岛素样生长因子1|IGF-1]] ([[胰岛素样生长因子1]]; [[mecasermin]], [[mecasermin rinfabate]])<br />
* [[Insulin-like growth factor 2|IGF-2 (somatomedin A)]]<!--<br />'''拮抗劑:'''--><br />
<br />
| group2 = [[Insulin-like growth factor 2 receptor|IGF-2]]<br />
| list2 =<br />
* '''激動劑''': [[Insulin-like growth factor 2|IGF-2 (somatomedin A)]]<!--<br />'''拮抗劑:'''--><br />
<br />
}}<br />
<br />
| group18 = [[生長抑素受體]]<br />
| list18 = <br />
* '''激動劑:''' [[BIM-23052]]<br />
* [[CH-275]]<br />
* [[Cortistatin-14]]<br />
* [[Depreotide]]<br />
* [[Ilatreotide]]<br />
* [[L-803,087]]<br />
* [[L-817,818]]<br />
* [[兰瑞肽]]<br />
* [[NNC 26-9100]]<br />
* [[Octreotide]]<br />
* [[Pasireotide]]<br />
* [[Pentetreotide]]<br />
* [[RC-160]]<br />
* [[Seglitide]]<br />
* [[體抑素]]<br />
* [[Somatostatin (1-28)]]<br />
* [[SRIF-14]]<br />
* [[SRIF-28]]<br />
* [[TT-232]]<br />
* [[Vapreotide]]<br />'''拮抗劑:''' [[BIM-23056]]<br />
* [[Cyclosomatostatin]]<br />
* [[CYN-154806]]<br />
* [[兰瑞肽]]<br />
<br />
| group19 = [[促甲状腺激素释放激素受体|TRH]]<br />
| list19 = <br />
* '''激動劑:''' [[Azetirelin]]<br />
* [[Fertirelin]]<br />
* [[Montirelin]]<br />
* [[Orotirelin]]<br />
* [[Posatirelin]]<br />
* [[甲狀腺促素釋素]]<br />
* [[Rovatirelin]]<br />
* [[Taltirelin]]<br />
* [[甲狀腺促素釋素|TRH/TRF]]<!--<br />'''拮抗劑:'''--><br />
<br />
| group20 = [[促甲状腺激素受体|TSH]]<br />
| list20 = <br />
* '''激動劑:''' [[促甲状腺激素]]<!--<br />'''拮抗劑:'''--><br />
<br />
}}<noinclude><br />
{{Navbox documentation}}<br />
[[Category:受体、通道、泵的药物模板]]<br />
[[Category:各作用机制药物]]<br />
</noinclude></div>
imported>Cewbot